Name: Eledon Pharmaceuticals, Inc. (ELDN) Cash Flow Statement
Creator: FinSpry

Eledon Pharmaceuticals Cash Flow Statement Analysis

Operating, investing, and financing activities in millions USD

Scale:

Scroll to see more

Cash flow statement showing operating, investing, and financing activities for Eledon Pharmaceuticals, Inc. (ELDN) - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018
Operating Activities
Net Income	-36.18	-116.54	-87.97	-34.51	-22.81	-16.01	-14.07
Depreciation & Amortization	0.36	0.37	0.37	0.20	0.18	0.18	0.01
Deferred Income Tax	0.43	0.00	0.00	-2.35	-0.40	0.00	0.00
Stock Based Compensation	13.12	6.55	8.15	7.90	3.17	0.00	0.00
Change in Working Capital	8.71	-4.92	0.65	0.05	-0.18	-1.04	0.62
Change in Accounts Payable	7.75	-2.60	2.08	2.14	-0.04	0.00	0.00
Change in Other Working Capital	0.96	-2.32	0.29	-2.30	-0.14	0.00	0.00
Other Operating Activities	-30.48	76.21	58.52	7.70	7.79	3.01	0.00
Net Cash from Operating Activities	-47.27	-39.53	-28.42	-28.91	-15.21	-13.86	-11.89
Investing Activities
Acquisitions	0.00	0.00	0.00	0.00	11.04	0.00	0.00
Purchases of Investments	-70.31	-78.29	0.00	0.00	0.00	0.00	0.00
Sales/Maturities of Investments	85.82	33.00	0.00	0.00	0.00	0.00	0.00
Net Cash from Investing Activities	-70.31	-45.29	0.00	0.00	11.04	0.00	0.00
Financing Activities
Common Stock Issued	133.52	33.02	0.00	-0.45	9.00	9.68	7.49
Common Stock Repurchased	0.00	0.00	0.00	0.00	-0.03	0.00	0.00
Other Financing Activities	0.22	0.00	0.00	-0.45	-0.03	0.00	0.00
Net Cash from Financing Activities	133.52	33.02	0.00	-0.45	109.58	9.68	7.56
Summary
Net Change in Cash	15.94	-51.80	-28.42	-29.36	105.40	-4.18	-4.33
Cash at Beginning of Period	4.61	56.41	84.83	114.20	8.79	12.97	17.30
Cash at End of Period	20.55	4.61	56.41	84.83	114.20	8.79	12.97
Free Cash Flow	-47.27	-39.53	-28.42	-28.91	-15.21	-13.86	-11.89